UnknownPhase 2NCT06054217
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Studying Demodicidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Principal Investigator
- Mitchell C Shultz, MDShultz Chang Vision
- Intervention
- Vehicle of TP-03(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (2)
- Shultz Chang Vision, Northridge, California, United States
- Vita Eye Clinic, Shelby, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06054217 on ClinicalTrials.gov